SuperworthKairos Pharma, LTD. market cap KAPA
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $1.9M
- Highest close in our data
- $36.5M
- Sep 2025
Kairos Pharma, LTD. is worth $1.9M at the close on Oct 23, 2026, at $0.56 a share.
That is down 92% over the last year.
Its highest close in our data was $36.5M in Sep 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.9M | $1.9M | $18.3M | −87% |
| 2025 | $14.8M | $8M | $36.5M | −32% |
| 2024 | $21.6M | $18.8M | $21.8M | n/a |
Against its peers
Companies in Healthcare nearest Kairos Pharma, LTD.'s size, closest first, today.
| Company | Market cap |
|---|---|
| KAPAKairos Pharma, LTD. | $1.9M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| BCGBinah Capital | $18.2M |
| Peer median | $13.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Kairos Pharma, LTD.
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.